These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 24503730)
1. [The new 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk: comparison with the ESC/EAS recommendations for the management of dyslipidemias]. Catapano AL; Averna M; Faggiano P; Novo S G Ital Cardiol (Rome); 2014 Jan; 15(1):19-20. PubMed ID: 24503730 [No Abstract] [Full Text] [Related]
2. The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. Ray KK; Kastelein JJ; Boekholdt SM; Nicholls SJ; Khaw KT; Ballantyne CM; Catapano AL; Reiner Ž; Lüscher TF Eur Heart J; 2014 Apr; 35(15):960-8. PubMed ID: 24639424 [TBL] [Abstract][Full Text] [Related]
3. New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus? Reiner Z Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):724-7. PubMed ID: 21945917 [No Abstract] [Full Text] [Related]
4. [New european guidelines for dyslipidemia]. Riesen WF; Virgini V; Vogt B; Rodondi N Rev Med Suisse; 2012 Mar; 8(331):525-6, 528-30. PubMed ID: 22471115 [TBL] [Abstract][Full Text] [Related]
5. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). ; Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Perrone Filardi P; Riccardi G; Storey RF; Wood D; Atherosclerosis; 2011 Jul; 217 Suppl 1():S1-44. PubMed ID: 21723445 [No Abstract] [Full Text] [Related]
6. Population Effect of Differences in Cholesterol Guidelines in Eastern Europe and the United States. Lee JC; Zdrojewski T; Pencina MJ; Wyszomirski A; Lachacz M; Opolski G; Bandosz P; Rutkowski M; Gaciong Z; Wyrzykowski B; Navar AM JAMA Cardiol; 2016 Sep; 1(6):700-7. PubMed ID: 27434662 [TBL] [Abstract][Full Text] [Related]
7. Merits and potential downsides of the 2013 ACC/AHA cholesterol management guidelines. Gotto AM; Moon JE Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):573-6. PubMed ID: 24819819 [TBL] [Abstract][Full Text] [Related]
8. [Guidelines for the management of dyslipidemia]. Díaz Rodríguez Á; Semergen; 2014 Sep; 40 Suppl 4():19-25. PubMed ID: 25595349 [TBL] [Abstract][Full Text] [Related]
9. New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines. Raygor V; Khera A Curr Cardiol Rep; 2020 Jul; 22(9):87. PubMed ID: 32647997 [TBL] [Abstract][Full Text] [Related]
10. The new joint EAS/ESC guidelines for the management of dyslipidaemias. Catapano AL; Chapman J; Wiklund O; Taskinen MR Atherosclerosis; 2011 Jul; 217(1):1. PubMed ID: 21722901 [No Abstract] [Full Text] [Related]
11. [Prevention and treatment of atherosclerosis and cardiovascular diseases]. Knobler H; Bitzur R; Gavish D; Rubinstein A; Henkin Y; Chajek-Shaul T; Harats D Harefuah; 2012 May; 151(5):281-8, 319, 318. PubMed ID: 22844732 [TBL] [Abstract][Full Text] [Related]
13. [Consensus standpoints from expert panel of Chinese Society of Cardiology on AHA/ACC 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults]. Yan X; Chen H; Gao W; Li J; Yang X; Ye P; Zhang S; Zhao D; Zhu J; Huo Y Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):275-6. PubMed ID: 24924450 [No Abstract] [Full Text] [Related]
15. The 2013 American College of Cardiology/American Heart Association guidelines on treating blood cholesterol and assessing cardiovascular risk: a busy practitioner's guide. Gupta A; Smith DA Endocrinol Metab Clin North Am; 2014 Dec; 43(4):869-92. PubMed ID: 25432387 [TBL] [Abstract][Full Text] [Related]
16. Management of inherited atherogenic dyslipidemias in children. Guardamagna O; Cagliero P; Abello F Ther Apher Dial; 2013 Apr; 17(2):150-61. PubMed ID: 23551671 [TBL] [Abstract][Full Text] [Related]
17. Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritis. Tournadre A; Tatar Z; Pereira B; Chevreau M; Gossec L; Gaudin P; Soubrier M; Dougados M Int J Cardiol; 2015 Mar; 183():149-54. PubMed ID: 25666124 [TBL] [Abstract][Full Text] [Related]
18. The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components. Virani SS Tex Heart Inst J; 2016 Aug; 43(4):313-4. PubMed ID: 27547139 [No Abstract] [Full Text] [Related]
19. [Spanish interdisciplinary committee for cardiovascular disease prevention and the spanish society of cardiology position statement on dyslipidemia management. Differences between the European and american guidelines]. Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR; Semergen; 2015 Apr; 41(3):149-57. PubMed ID: 25450438 [TBL] [Abstract][Full Text] [Related]
20. Current ways of treating dyslipidemias to prevent atherosclerosis. Angelico F; Baratta F; Del Ben M Ther Apher Dial; 2013 Apr; 17(2):125-9. PubMed ID: 23551668 [No Abstract] [Full Text] [Related] [Next] [New Search]